ADGRL4 and neoplasm: Tumour growth was monitored via MRI every 3–4 days, and the animals were either left untreated or treated via tail vein upon tumour detection with either mmAb anti‐ELTD1 Ab or bevacizumab (2 mg/kg), or given OKN via the drinking water.